Mobile Cardiac Telemetry Systems Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Multiple Lead Mobile Cardiac Telemetry System, Mobile Cardiac Telemetry Patch), By Disease Indication (Angina Pectoris, Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Others), By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Home Care setting, Others) and Region Forecast 2020-2031

Mobile Cardiac Telemetry Systems Market size was valued at US$ 1,432.9 million in 2024 and is expected to reach US$ 3,267.5 million by 2031, growing at a significant CAGR of 12.5% from 2025-2031. Moreover, the U.S. market is projected to grow at 12.8% CAGR over the forecast period. The Mobile Cardiac Telemetry (MCT) Systems Market refers to the segment of cardiac monitoring technologies that provide real-time, continuous, and remote monitoring of a patient’s cardiac activity. These systems are primarily used to detect arrhythmias and other heart conditions by transmitting data wirelessly to a centralized diagnostic centre. MCT systems are a part of ambulatory cardiac monitoring devices and represent an advancement over traditional Holter monitors and event recorders due to their ability to provide automatic detection and immediate reporting of cardiac anomalies.

The MCT systems market has witnessed significant growth in recent years, driven by the increased prevalence of cardiovascular diseases, advancements in wireless and wearable technologies, and a growing preference for real-time and remote patient monitoring. The market is further fuelled by the rising geriatric population, increased adoption of telehealth services, and favourable reimbursement policies in developed markets. With a strong demand from hospitals, diagnostic centres, and homecare settings, the market continues to expand, especially in North America and Europe, while emerging economies show promising growth potential due to improving healthcare infrastructure.

Facts and Figures:

• Prevalence of Heart Disease: In accordance with World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, with approximately 17.9 million people dying each year, making continuous cardiac monitoring solutions, like MCT systems, essential in managing such conditions.
• Growth in Remote Monitoring Devices: The global market for wearable medical devices, which includes MCT systems, is expected to grow significantly, with estimates suggesting a compound annual growth rate (CAGR) of over 20% in the coming years, as more patients and healthcare providers embrace remote health monitoring solutions.
• Aging Population Impact: The World Population Prospects report highlights that by 2030, the global population aged 60 years or older is expected to reach 1.4 billion. This demographic shift is expected to drive further demand for MCT systems, as older populations are more prone to heart-related conditions, increasing the need for continuous cardiac monitoring.

Key Developments:

• In October 2024, iRhythm Technologies, Inc., a prominent digital healthcare company focused on developing trusted solutions for disease detection, prediction, and prevention, announced that the U.S. Food and Drug Administration (FDA) granted clearance for its 510(k) submission regarding recent design changes made to the Zio AT device through a letter to file. The Zio AT device continues to be commercially available for shipment to customers across the United States.
• In May 2024, at the Heart Rhythm Annual Meeting in Boston, Philips showcased the clinical and economic benefits of its AI-powered cardiac monitoring solutions. The studies highlighted the critical role of mobile cardiac monitoring technology in improving the early detection of adverse cardiac events, enabling life-saving interventions, while also reducing readmissions and lowering healthcare costs.

Mobile Cardiac Telemetry Systems Market Segmentation:

Based on the component:

• Devices
• Software
• Services

Among the components, devices are anticipated to lead the Mobile Cardiac Telemetry (MCT) Systems Market due to the growing demand for real-time, remote cardiac monitoring solutions. These devices enable continuous tracking of heart activity, offering faster diagnosis and intervention for cardiac events such as arrhythmias. The rise in cardiovascular disease prevalence, coupled with increased awareness of preventive healthcare, is driving the adoption of MCT devices in clinical and homecare settings. Additionally, technological advancements have made these devices more compact, accurate, and user-friendly, further boosting their market share. As a result, devices are expected to remain the dominant segment in the coming years.

Based on the application:

• Atrial Fibrillation
• Bradycardia
• Tachycardia
• Ventricular Fibrillation
• Others

Based on application, atrial fibrillation is expected to dominate the Mobile Cardiac Telemetry (MCT) Systems Market. Atrial fibrillation (AF) is one of the most common types of arrhythmias, affecting millions of individuals worldwide, particularly the elderly population. The condition often goes undetected due to its intermittent nature, making continuous monitoring essential for accurate diagnosis and timely intervention. MCT systems are highly effective in identifying irregular heart rhythms associated with AF, even when symptoms are not present. With the growing prevalence of AF and increasing awareness among patients and healthcare providers, the demand for MCT systems in this segment is projected to remain strong and lead the market.

Based on the end user:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• Home Healthcare
• Others

Among the end users, hospitals are expected to lead the Mobile Cardiac Telemetry (MCT) Systems Market. This is primarily due to the high volume of patients requiring continuous cardiac monitoring in hospital settings, especially those with chronic conditions such as atrial fibrillation or heart failure. Hospitals are increasingly adopting MCT systems to enhance patient care by enabling real-time monitoring, early detection, and timely interventions. With the ongoing expansion of healthcare infrastructure and growing awareness of the importance of remote monitoring in improving patient outcomes, hospitals are anticipated to remain the dominant end user in the MCT market.